Summarized by Masters of Longevity from Longevity Docs News.
Combination therapy cut total coronary plaque volume more than high-dose atorvastatin.
Key Takeaways
- Rosuvastatin plus ezetimibe lowered LDL to about 42 mg/dL.
- Combination therapy reduced total coronary plaque volume by 21%.
- The trial was small and did not measure heart attacks or deaths.
